This post is from a suggested group
The Global Fabry Disease Market: Fueling Growth with Novel Therapies and Diagnosis
The Global Fabry Disease Market is poised for substantial growth, driven by an increasing understanding of this rare, inherited lysosomal storage disorder and the rapid development of innovative treatments. Valued at $2.44 Billion in 2024, the market is projected to more than double, reaching an estimated $5.17 Billion by 2034, propelled by a robust Compound Annual Growth Rate (CAGR) of 7.82% from 2025 to 2034. This significant upward trajectory underscores the successful transition from symptomatic management to targeted therapeutic interventions.
A primary driver for this market expansion is the increasing prevalence and better identification of the disease globally. While traditionally considered extremely rare, modern screening techniques have revealed that the "later-onset" Type 2 phenotype may be 3 to 10 times more common than the classical Type 1, affecting a significant portion of the male population in some areas.…